We advised Privia Health on its IPO and Nasdaq listing

Davis Polk advised Privia Health Group, Inc. on its $131.7 million initial public offering of 5,725,000 shares of common stock, including 2,925,000 shares purchased pursuant to the full exercise of the underwriters’ over-allotment option. Privia Health’s majority shareholder sold an additional 16,700,000 shares in the offering for a total offering size of $525.8 million. The shares of common stock are listed on the Nasdaq Global Select Market under the symbol “PRVA.”

Privia Health is a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health’s platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes and improves the health of patients and the well-being of providers.

The Davis Polk capital markets team included partners Richard D. Truesdell Jr. and Roshni Banker Cariello and associates Chris Van Buren and Michael Jiang. The executive compensation team included partner Kyoko Takahashi Lin and counsel Stephen I. Brecher. The intellectual property and technology transactions team included partner Pritesh P. Shah and associate Jesse L. Hallock. The tax team included partner Michael Mollerus and associate Daniel L. Jose. All members of the Davis Polk team are based in the New York office.